- Home
- CASI vs SGRP Comparison
CASI vs SGRP Comparison
Compare CASI & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- SGRP
- Stock Information
- Founded
- CASI 1991
- SGRP 1967
- Country
- CASI China
- SGRP United States
- Employees
- CASI N/A
- SGRP N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- CASI Health Care
- SGRP Consumer Discretionary
- Exchange
- CASI Nasdaq
- SGRP Nasdaq
- Market Cap
- CASI 24.9M
- SGRP 27.3M
- IPO Year
- CASI 1996
- SGRP 1996
- Fundamental
- Price
- CASI $1.30
- SGRP $0.95
- Analyst Decision
- CASI Strong Buy
- SGRP
- Analyst Count
- CASI 1
- SGRP 0
- Target Price
- CASI $4.00
- SGRP N/A
- AVG Volume (30 Days)
- CASI 26.7K
- SGRP 50.3K
- Earning Date
- CASI 11-14-2025
- SGRP 11-14-2025
- Dividend Yield
- CASI N/A
- SGRP N/A
- EPS Growth
- CASI N/A
- SGRP N/A
- EPS
- CASI N/A
- SGRP N/A
- Revenue
- CASI $31,564,000.00
- SGRP $143,501,000.00
- Revenue This Year
- CASI N/A
- SGRP $7.22
- Revenue Next Year
- CASI N/A
- SGRP N/A
- P/E Ratio
- CASI N/A
- SGRP N/A
- Revenue Growth
- CASI 36.64
- SGRP N/A
- 52 Week Low
- CASI $1.09
- SGRP $0.91
- 52 Week High
- CASI $5.95
- SGRP $2.41
- Technical
- Relative Strength Index (RSI)
- CASI 35.39
- SGRP 35.04
- Support Level
- CASI $1.29
- SGRP $1.04
- Resistance Level
- CASI $1.48
- SGRP $1.09
- Average True Range (ATR)
- CASI 0.13
- SGRP 0.05
- MACD
- CASI -0.00
- SGRP -0.01
- Stochastic Oscillator
- CASI 0.00
- SGRP 22.81
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.